SUVN-911

· Suven Life Sciences Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SUVN-911, covering 2018-05-29 to 2018-05-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects [Phase 1]